Cargando…
Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P.
In recent years, radiolabelled monoclonal antibodies have been evaluated for their use in the diagnosis and treatment of neoplastic disease. One isotope which has not been assessed for antibody targeting is 32P, even though it has many favourable radiobiological characteristics and has been used cli...
Autores principales: | Foxwell, B. M., Band, H. A., Long, J., Jeffery, W. A., Snook, D., Thorpe, P. E., Watson, G., Parker, P. J., Epenetos, A. A., Creighton, A. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246391/ https://www.ncbi.nlm.nih.gov/pubmed/3395553 |
Ejemplares similares
-
Monoclonal antibodies for imaging and therapy.
por: Epenetos, A. A., et al.
Publicado: (1989) -
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.
por: Hird, V., et al.
Publicado: (1993) -
Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens.
por: Kosmas, C., et al.
Publicado: (1991) -
Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.
por: Sivolapenko, G. B., et al.
Publicado: (1991) -
Development of a novel bi-specific monoclonal antibody approach for tumour targeting
por: Koumarianou, A A, et al.
Publicado: (1999)